Drug
Ziprazidone
Ziprazidone: highest development phase Post-Market, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| ziprazidone NCT00159757 | Post-Market | Schizophrenia |
Latest
No recent events.
Follow Ziprazidone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.